The decision by Trump’s team to tap Heather Flick as HHS chief of staff signals an effort to keep closer watch on the ...
In its final days, the Biden administration's FDA is expected to propose a limit on the amount of nicotine in cigarettes.
J&J agreed to buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of reentry into neuroscience by large ...
Dr. Scott Manthei of the Nevada Ear and Sinus Institute has been advising patients against taking drugs like Sudafed for ...
Endpoints Weekly reports on iECURE's gene therapy success for OTC deficiency, FDA CDER director Patrizia Cavazzoni's departure, and Verdiva Bio's $411M launch with Sciwind assets.
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
FDA's Center for Drug Evaluation and Research director, Patrizia Cavazzoni, MD, to step down in mid-January. Other top leaders also leaving FDA.
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
According to CDER Director Patrizia Cavazzoni, CDER’s new Center for Real-World Evidence Innovation represents a major step ...
The reason for the recall is that "eggs from a positive Salmonella environment were shipped into distribution to retail facilities," according to the FDA. Handsome Brook Farms issued the voluntary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback